Matches in Wikidata for { <http://www.wikidata.org/entity/Q92274124> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q92274124 description "clinical trial" @default.
- Q92274124 description "ensayo clínico" @default.
- Q92274124 description "ensayu clínicu" @default.
- Q92274124 description "klinisch onderzoek" @default.
- Q92274124 description "клінічне випробування" @default.
- Q92274124 description "կլինիկական փորձարկում" @default.
- Q92274124 description "临床试验" @default.
- Q92274124 name "Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (Over 12 Years) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis" @default.
- Q92274124 name "Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric" @default.
- Q92274124 type Item @default.
- Q92274124 label "Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (Over 12 Years) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis" @default.
- Q92274124 label "Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric" @default.
- Q92274124 prefLabel "Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (Over 12 Years) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis" @default.
- Q92274124 prefLabel "Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric" @default.
- Q92274124 P1050 Q92274124-1064AFD6-9E40-431A-9DA0-1C202C4F5D2C @default.
- Q92274124 P1050 Q92274124-1232736C-881C-4E8E-9E72-FC6D3FF40B4B @default.
- Q92274124 P1050 Q92274124-684212CD-9408-4B1D-B0BD-F16774606A83 @default.
- Q92274124 P1050 Q92274124-A45F63C6-B8F9-487C-A5F2-84635422651C @default.
- Q92274124 P1132 Q92274124-E89E8DBC-FF24-4DBB-92E2-94DA904FE4FE @default.
- Q92274124 P1476 Q92274124-BA8B942C-A215-40E9-9AB5-8A2F8A6198A3 @default.
- Q92274124 P1813 Q92274124-573095EA-4CAE-4916-AF04-1DB44C2878A8 @default.
- Q92274124 P2899 Q92274124-8C7D4F8B-4E1A-44AB-9EC8-2193B1C7773F @default.
- Q92274124 P3098 Q92274124-B8AB967B-2EC9-428B-9AF6-1A45396202DB @default.
- Q92274124 P31 Q92274124-4ED8A9C7-BAF1-4C1D-B795-7915F09C7DDB @default.
- Q92274124 P580 Q92274124-A4DCAE72-7F49-4026-A8E0-853CF57CC8FF @default.
- Q92274124 P582 Q92274124-D1E3441A-B982-45E9-8FBD-A193324C6C75 @default.
- Q92274124 P8005 Q92274124-21115C61-DFFB-4BCF-B1F8-DBBD27F23103 @default.
- Q92274124 P8363 Q92274124-DF747BBB-DA01-4C67-82AF-F7EF3C44A98F @default.
- Q92274124 P921 Q92274124-52EA8BF1-40A4-455E-A45C-B2767449FE44 @default.
- Q92274124 P1050 Q131742 @default.
- Q92274124 P1050 Q147778 @default.
- Q92274124 P1050 Q154869 @default.
- Q92274124 P1050 Q157661 @default.
- Q92274124 P1132 "+99" @default.
- Q92274124 P1476 "REAl World Evidence Of The Effectiveness And Clinical Practice Use Of Glecaprevir/Pibrentasvir For 8 Weeks Treatment In Patients With Chronic HepatitiS C GenotYpes 1 to 6 And Liver Cirrhosis In Russian Federation (EASY)" @default.
- Q92274124 P1813 "EASY" @default.
- Q92274124 P2899 "+12" @default.
- Q92274124 P3098 "NCT04352309" @default.
- Q92274124 P31 Q30612 @default.
- Q92274124 P580 "2020-05-11T00:00:00Z" @default.
- Q92274124 P582 "2021-01-06T00:00:00Z" @default.
- Q92274124 P8005 Q76649614 @default.
- Q92274124 P8363 Q818574 @default.
- Q92274124 P921 Q147778 @default.